A Study of LY3541105 in Healthy and Overweight Participants
Status:
Recruiting
Trial end date:
2023-08-04
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to evaluate the safety and tolerability of LY3541105 in
healthy and overweight participants. Blood tests will be performed to check how much
LY3541105 gets into the bloodstream and how long it takes the body to eliminate it. The study
will also evaluate the effects of LY3541105 on body weight. This is a 2-part study and may
last up to 15 and 26 weeks for each participant and may include up to 7 and 15 visits in
parts A and B, respectively.